Primary Site >> Colorectal Cancer
Gene >> RBM39
| 1. | |||||||||||
| Journal: | Br J Cancer. 2009 Dec 3;101 Suppl 2:S80-6. | ||||||||||
| Title: | The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. | ||||||||||
| Author: | Hamilton, W | ||||||||||
| PMID: | 19956169 | ||||||||||
| 2. | |||||||||||
| Journal: | Gut. 2011 Sep;60(9):1242-8. | ||||||||||
| Title: | The diagnostic performance of scoring systems to identify symptomatic colorectal cancer compared to current referral guidance. | ||||||||||
| Author: | Marshall, Tom|Lancashire, Robert|Sharp, Debbie|Peters, Tim J|Cheng, K K|Hamilton, William | ||||||||||
| PMID: | 21357592 | ||||||||||
| 3. | |||||||||||
| Journal: | Gut. 2012 Nov;61(11):1568-75. Epub 2011 Dec 29. | ||||||||||
| Title: | TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression. | ||||||||||
| Author: | Sillars-Hardebol, Anke H|Carvalho, Beatriz|Tijssen, Marianne|Belien, Jeroen A M|de Wit, Meike|Delis-van Diemen, Pien M|Ponten, Fredrik|van de Wiel, Mark A|Fijneman, Remond J A|Meijer, Gerrit A | ||||||||||
| PMID: | 22207630 | ||||||||||
| 4. | |||||||||||
| Journal: | Cell Oncol (Dordr). 2012 Aug;35(4):293-300. | ||||||||||
| Title: | CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression. | ||||||||||
| Author: | Sillars-Hardebol, Anke H|Carvalho, Beatriz|Belien, Jeroen A M|de Wit, Meike|Delis-van Diemen, Pien M|Tijssen, Marianne|van de Wiel, Mark A|Ponten, Fredrik|Meijer, Gerrit A|Fijneman, Remond J A | ||||||||||
| PMID: | 22711543 | ||||||||||